$Flexion Therapeutics(FLXN)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001564590-20-019696 Act: 34 Size: 174 KB 网页链接
$Flexion Therapeutics(FLXN)$ DEF 14A Other definitive proxy statements Accession Number: 0001564590-20-019691 Act: 34 Size: 1 MB 网页链接
$Flexion Therapeutics(FLXN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-023097 Size: 9 KB 网页链接
$Flexion Therapeutics(FLXN)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001564590-20-014651 Act: 34 Size: 412 KB 网页链接
$Flexion Therapeutics(FLXN)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001209191-20-018851 Size: 6 KB 网页链接
$Flexion Therapeutics(FLXN)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001564590-20-010521 Act: 33 Size: 165 KB 网页链接
$Flexion Therapeutics(FLXN)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001564590-20-010490 Act: 34 Size: 13 MB 网页链接
$Flexion Therapeutics(FLXN)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001564590-20-010448 Act: 34 Size: 2 MB 网页链接
$Flexion Therapeutics(FLXN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-015148 Size: 7 KB 网页链接
$Flexion Therapeutics(FLXN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-015120 Size: 7 KB 网页链接